Forepont Capital Partners
Forepont Capital Partners, founded in 2017 in New York, is a global asset manager specializing in healthcare and life sciences. The firm focuses on investing in biotech, medtech, and e-health start-ups in the United States and Europe, providing scientific, technological, financial, and operational support to improve their performance. Forepont is committed to advancing medical research and innovation, particularly in neurology, and has established strong partnerships with industry leaders, academia, and large pharmaceutical groups.
Forepont Capital Partners
What We Do
Forepont provides comprehensive support to its portfolio companies, leveraging its expertise and global ecosystem to enhance their performance.
Forepont offers privileged access to new opportunities through its established healthcare partnerships, ensuring a thorough consideration of medical, human, financial, and ethical factors before investment.
With deep knowledge of American and European regulations, Forepont provides crucial support at both local and international levels.